US 7566465
Artemisinins in the clinical and veterinary management of kinetoplastid infections
granted A61KA61K31/357A61K31/366
Quick answer
US patent 7566465 (Artemisinins in the clinical and veterinary management of kinetoplastid infections) held by The United States of America as represented by the Secretary of the Army expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/357, A61K31/366, A61K36/282, A61P